Entwicklung einer Tierversuchsersatzmethode für endokrine Disruptoren - Grundlagenuntersuchungen am Hühnerembryo

In recent decades, the number of animals used in research and medical technology has increased due to increasing regulatory requirements and new legislations for chemicals. This is because newly developed chemicals possess additional mode of action properties and therefore need to be tested in animal systems for human and environmental risk assessment. The chemicals enter the environment in different ways and finally might negatively affect human and animal health. In the methods used so far for environmental risk assessment, juvenile or adult animals are mainly taken for the assessment of substances, partially even in complete generation tests with whole animals. It is known that the development of reproductive disorders occurs in the embryonic phase of the respective individuals, when all properties of the later individual are being formed. In order to reduce animal consumption, some in vitro test systems are used. However, these tests mostly indicate a specific cell type at a certain stage of development, which severely limits the significance of the actual effect compared to a complex tissue, if not to speak of the complete organism and its development. Thus, the power of this method must be seen within certain restrictions. In the presented work, an alternative replacement method is presented with the aim of increasing the significance of toxicologically and ecotoxicologically relevant endpoints. The focus is on the effects of androgenic and estrogenic substances on the sexual development of chicken embryos (Gallus gallus domesticus) at the level of whole mRNA expression of gonads, combined with effects at the level of organ histology and morphology compared to the normal conditions of untreated individuals. The method can be used in the context of human and environmental risk assessment of substances and is a suitable tool to carry out the necessary studies with the required high quality of assessment. At the same time, this animal test replacement method with high potency might reduce the consumption of higher experimental animals, which also corresponds to a socio-ethical need.Auf den Einsatz von Tieren im Rahmen der (Umwelt-)Risikobewertung von Stoffen kann nach wie vor nicht verzichtet werden. Dabei führen die Überprüfungen einer zunehmenden Anzahl neu entwickelter Stoffe, aber auch die gestiegenen Anforderungen der Gesetzgebungen zu einem hohen Verbrauch von Versuchstieren. Diese Untersuchungen sind wichtig, da viele der in Gebrauch befindlichen und in allen Bereichen genutzten Chemikalien potentiell endokrin wirksam sind, auf unterschiedlichen Wegen in die Umwelt gelangen und sich potentiell negativ auf die Gesundheit von Mensch und Tier auswirken können. Bei den bisher verwendeten Methoden werden vor allem juvenile oder adulte Tiere, aber auch Tiere zur Untersuchung des kompletten Lebenszyklus über eine oder mehrere Generationen für die Beurteilung von Substanzen eingesetzt. Dabei ist bekannt, dass die Entstehung reproduktiver Störungen in der Embryonalphase der jeweiligen Individuen auftritt. Um den Tierverbrauch zu reduzieren, werden teilweise In-vitro-Testsysteme angewendet. Es zeigt sich aber, dass diese Tests lediglich einen bestimmten Zelltyp in einem bestimmten Entwicklungsstadium abbilden können, was die Aussagekraft über die tatsächliche Wirkung auf ein komplexes Gewebe und dessen Entwicklung, erst Recht für den kompletten Organismus, stark einschränkt. Die Aussagekraft dieser Methoden ist daher in bestimmten eingeschränkten Grenzen zu sehen. In der vorliegenden Arbeit wird eine alternative Ersatzmethode vorgestellt mit dem Ziel einer stärkeren Aussagekraft bei toxikologisch und ökotoxikologisch relevanten Endpunkten. Im Fokus stehen hierbei die Effekte von androgenen und estrogenen Substanzen auf die Geschlechtsentwicklung von Hühnerembryonen (Gallus gallus domesticus) auf Ebene der Expression der mRNA, vereint mit Effekten auf Ebene der Organhistologie und – morphologie, verglichen mit den Normalzuständen unbehandelter Individuen. Die neu entwickelte Methode zur Beurteilung solcher Substanzen kann im Rahmen der human- und umwelttoxikologischen Risikobewertung von Stoffen eingesetzt werden und ist ein geeignetes Werkzeug, um die notwendigen Untersuchungen mit der gefordert hohen Beurteilungsqualität durchzuführen. Gleichzeitig kann mit dieser Tierversuchsersatzmethode bei hoher Aussagekraft auch der Verbrauch an weiter und höher entwickelten Versuchstieren verringert werden, was auch einem gesellschaftlich-ethischen Bedürfnis gerecht wird

The domestic fowl (Gallus gallus domesticus) embryo as an alternative for mammalian experiments – validation of a test method for the detection of endocrine disrupting chemicals

In recent decades the embryo of Gallus g. domesticus has been widely used as a model for the study of early sexual development and the potential impact of substances affecting development, including endocrine disrupting chemicals (EDCs). Since there is no standardized procedure available for experiments with the chicken embryo, the objective of our project is to expedite the protocol to assess the potential effects of EDCs on early sexual differentiation. The main aim of the present study was to systematically investigate the natural variability of individual developmental and histological key parameters in untreated and solvent-treated control groups, since this has been insufficiently addressed so far. A further aim was to provide robust values for all parameters investigated in control and substance experiments, using two known estrogenic compounds, bisphenol A (75/150/300 μg/g egg) and 17α-ethinylestradiol (20 ng/g egg). On embryonic day 1 eggs were injected with the estrogenic compounds. On embryonic day 19 histological gonadal data as well as morphological parameters were noted. In baseline experiments with control groups the selected endpoints showed reproducible results with low variabilities. Furthermore, gonadal endpoints responded sensitively to the treatment with the two model EDCs. Thus, these endpoints are recommended for the assessment of suspected EDCs in which the values provided for all parameters can serve as validity criteria in future experiments. The embryo of G. domesticus has shown to be a suitable alternative to currently accepted mammalian bioassays for the impact assessment of EDCs on reproductive tissues

Morphological and transcriptomic effects of endocrine modulators on the gonadal differentiation of chicken embryos: the case of tributyltin (TBT)

Morphological malformations induced by tributyltin (TBT) exposure during embryonic development have already been characterized in various taxonomic groups, but, nonetheless, the molecular processes underlying these changes remain obscure. The present study provides the first genome-wide screening for differentially expressed genes that are linked to morphological alterations of gonadal tissue from chicken embryos after exposure to TBT. We applied a single injection of TBT (between 0.5 and 30 pg as Sn/g egg) into incubated fertile eggs to simulate maternal transfer of the endocrine disruptive compound. Methyltestosterone (MT) served as a positive control (30 pg/g egg). After 19 days of incubation, structural features of the gonads as well as genome-wide gene expression profiles were assessed simultaneously. TBT induced significant morphological and histological malformations of gonadal tissue from female embryos that show a virilization of the ovaries. This phenotypical virilization was mirrored by altered expression profiles of sex-dependent genes. Among these are several transcription and growth factors (e.g. FGF12, CTCF, NFIB), whose altered expression might serve as a set of markers for early identification of endocrine active chemicals that affect embryonic development by transcriptome profiling without the need of elaborate histological analyses

APADB : a database for alternative polyadenylation and microRNA regulation events

Alternative polyadenylation (APA) is a widespread mechanism that contributes to the sophisticated dynamics of gene regulation. Approximately 50% of all protein-coding human genes harbor multiple polyadenylation (PA) sites; their selective and combinatorial use gives rise to transcript variants with differing length of their 3' untranslated region (3'UTR). Shortened variants escape UTR-mediated regulation by microRNAs (miRNAs), especially in cancer, where global 3'UTR shortening accelerates disease progression, dedifferentiation and proliferation. Here we present APADB, a database of vertebrate PA sites determined by 3' end sequencing, using massive analysis of complementary DNA ends. APADB provides (A)PA sites for coding and non-coding transcripts of human, mouse and chicken genes. For human and mouse, several tissue types, including different cancer specimens, are available. APADB records the loss of predicted miRNA binding sites and visualizes next-generation sequencing reads that support each PA site in a genome browser. The database tables can either be browsed according to organism and tissue or alternatively searched for a gene of interest. APADB is the largest database of APA in human, chicken and mouse. The stored information provides experimental evidence for thousands of PA sites and APA events. APADB combines 3' end sequencing data with prediction algorithms of miRNA binding sites, allowing to further improve prediction algorithms. Current databases lack correct information about 3'UTR lengths, especially for chicken, and APADB provides necessary information to close this gap. Database URL: http://tools.genxpro.net/apadb